BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 25075421)

  • 21. GSK-3 parameters in postmortem frontal cortex and hippocampus of schizophrenic patients.
    Nadri C; Dean B; Scarr E; Agam G
    Schizophr Res; 2004 Dec; 71(2-3):377-82. PubMed ID: 15474909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low GSK-3beta in schizophrenia as a consequence of neurodevelopmental insult.
    Kozlovsky N; Nadri C; Agam G
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):1-11. PubMed ID: 15572268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycogen synthase kinase-3beta is activated by matrix metalloproteinase-2 mediated proteolysis in cardiomyoblasts.
    Kandasamy AD; Schulz R
    Cardiovasc Res; 2009 Sep; 83(4):698-706. PubMed ID: 19493954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GSK-3 parameters in lymphocytes of schizophrenic patients.
    Nadri C; Kozlovsky N; Agam G; Bersudsky Y
    Psychiatry Res; 2002 Sep; 112(1):51-7. PubMed ID: 12379450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycogen synthase kinase-3beta: a prognostic marker and a potential therapeutic target in human bladder cancer.
    Naito S; Bilim V; Yuuki K; Ugolkov A; Motoyama T; Nagaoka A; Kato T; Tomita Y
    Clin Cancer Res; 2010 Nov; 16(21):5124-32. PubMed ID: 20889919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leucine-rich repeat kinase 2 regulates tau phosphorylation through direct activation of glycogen synthase kinase-3β.
    Kawakami F; Shimada N; Ohta E; Kagiya G; Kawashima R; Maekawa T; Maruyama H; Ichikawa T
    FEBS J; 2014 Jan; 281(1):3-13. PubMed ID: 24165324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of glycogen synthase kinase 3 beta attenuates neurocognitive dysfunction resulting from cranial irradiation.
    Thotala DK; Hallahan DE; Yazlovitskaya EM
    Cancer Res; 2008 Jul; 68(14):5859-68. PubMed ID: 18632640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presenilin influences glycogen synthase kinase-3 β (GSK-3β) for kinesin-1 and dynein function during axonal transport.
    Dolma K; Iacobucci GJ; Hong Zheng K; Shandilya J; Toska E; White JA; Spina E; Gunawardena S
    Hum Mol Genet; 2014 Mar; 23(5):1121-33. PubMed ID: 24105467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between glycogen synthase kinase-3beta gene polymorphisms and major depression and suicidal behavior in a Korean population.
    Yoon HK; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):331-4. PubMed ID: 20015462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Wnt pool of glycogen synthase kinase 3beta is critical for trophic-deprivation-induced neuronal death.
    Hongisto V; Vainio JC; Thompson R; Courtney MJ; Coffey ET
    Mol Cell Biol; 2008 Mar; 28(5):1515-27. PubMed ID: 18195042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Glycogen synthase kinase-3beta (GSK-3beta) promotes proliferation of ovarian cancer cells in vitro].
    Cao Q; Feng YJ
    Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):804-9. PubMed ID: 17415999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Signaling pathways mediating phosphorylation and inactivation of glycogen synthase kinase-3β by the recombinant human δ-opioid receptor stably expressed in Chinese hamster ovary cells.
    Olianas MC; Dedoni S; Onali P
    Neuropharmacology; 2011 Jun; 60(7-8):1326-36. PubMed ID: 21276805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deletion of glycogen synthase kinase-3β in cartilage results in up-regulation of glycogen synthase kinase-3α protein expression.
    Gillespie JR; Ulici V; Dupuis H; Higgs A; Dimattia A; Patel S; Woodgett JR; Beier F
    Endocrinology; 2011 May; 152(5):1755-66. PubMed ID: 21325041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic correlational analysis of glycogen synthase kinase-3 beta and prepulse inhibition in inbred mice.
    Amar S; Jones BC; Nadri C; Kozlovsky N; Belmaker RH; Agam G
    Genes Brain Behav; 2004 Jun; 3(3):178-80. PubMed ID: 15140013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression, localization, and activity of glycogen synthase kinase 3beta during mouse skin tumorigenesis.
    Leis H; Segrelles C; Ruiz S; Santos M; Paramio JM
    Mol Carcinog; 2002 Dec; 35(4):180-5. PubMed ID: 12489109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycogen synthase kinase-3beta plays a pro-apoptotic role in beta-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes: Role of beta1 integrins.
    Menon B; Johnson JN; Ross RS; Singh M; Singh K
    J Mol Cell Cardiol; 2007 Mar; 42(3):653-61. PubMed ID: 17292911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Failure to support a genetic contribution of AKT1 polymorphisms and altered AKT signaling in schizophrenia.
    Ide M; Ohnishi T; Murayama M; Matsumoto I; Yamada K; Iwayama Y; Dedova I; Toyota T; Asada T; Takashima A; Yoshikawa T
    J Neurochem; 2006 Oct; 99(1):277-87. PubMed ID: 16987250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Schizophrenia, neurodevelopment and glycogen synthase kinase-3].
    Nadri C; Kozlovsky N; Agam G
    Harefuah; 2003 Sep; 142(8-9):636-42, 644. PubMed ID: 14518171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of endometrial glycogen synthase kinase-3beta protein throughout the menstrual cycle and its regulation by progesterone.
    Salameh W; Helliwell JP; Han G; McPhaul L; Khorram O
    Mol Hum Reprod; 2006 Sep; 12(9):543-9. PubMed ID: 16882987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced GSK-3beta mRNA levels in postmortem dorsolateral prefrontal cortex of schizophrenic patients.
    Kozlovsky N; Shanon-Weickert C; Tomaskovic-Crook E; Kleinman JE; Belmaker RH; Agam G
    J Neural Transm (Vienna); 2004 Dec; 111(12):1583-92. PubMed ID: 15565492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.